Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis
01 Pubblicazione su rivista
Lin Chunqing, Slama Jiri, Gonzalez Paula, Goodman Marc T, Xia Ningshao, Kreimer Aimée R, Wu Ting, Hessol Nancy A, Shvetsov Yurii, Ortiz Ana P, Grinsztejn Beatriz, Moscicki Anna-Barbara, Heard Isabelle, Del Refugio González Losa María, Kojic Erna M, Schim van der Loeff Maarten F, Wei Feixue, Longatto-Filho Adhemar, Mbulawa Zizipho A, Palefsky Joel M, Sohn Annette H, Hernandez Brenda Y, Robison Katina, Simpson Steve, Conley Lois J, de Pokomandy Alexandra, van der Sande Marianne A B, Dube Mandishora Racheal S, Volpini Lays P B, Pierangeli Alessandra, Romero Byron, Wilkin Timothy, Franceschi Silvia, Hidalgo-Tenorio Carmen, Ramautarsing Reshmie A, Park Ina U, Tso Fernanda K, Godbole Sheela, D', Hauwers Kathleen W M, Sehnal Borek, Menezes Lynette J, Heráclio Sandra A, Clifford Gary M
ISSN: 1473-3099
Cervical cancer screening might contribute to the prevention of anal cancer in women. We aimed to investigate if routine cervical cancer screening results-namely high-risk human papillomavirus (HPV) infection and cytohistopathology-predict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and, hence, anal cancer.